“Antibodies are driving a lot of the protection, but it's not the whole story”: A conversation with
CHED
11 episodes
2 weeks ago
Dr. David Benkeser talks about analyses of COVID-19 vaccine trials data on the immune response to those vaccines. We also discuss fluctuations in antibody levels and the potential for the trial data analyses to inform decisions on additional vaccine doses.
All content for “Antibodies are driving a lot of the protection, but it's not the whole story”: A conversation with is the property of CHED and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dr. David Benkeser talks about analyses of COVID-19 vaccine trials data on the immune response to those vaccines. We also discuss fluctuations in antibody levels and the potential for the trial data analyses to inform decisions on additional vaccine doses.
Dr. Carlos Del Rio on COVID-19 Equity and Outcomes
“Antibodies are driving a lot of the protection, but it's not the whole story”: A conversation with
5 minutes 46 seconds
5 years ago
Dr. Carlos Del Rio on COVID-19 Equity and Outcomes
Considering health equity and disparity, how will the pandemic progress? What is our current strategy? What can be and needs to be done to change the course of the pandemic? Listen to what Dr. Carlos Del Rio has to say.
“Antibodies are driving a lot of the protection, but it's not the whole story”: A conversation with
Dr. David Benkeser talks about analyses of COVID-19 vaccine trials data on the immune response to those vaccines. We also discuss fluctuations in antibody levels and the potential for the trial data analyses to inform decisions on additional vaccine doses.
